iSpecimen (ISPC) stock drops in premarket after $5.5 million convertible preferred financing
NEW YORK, December 31, 2025, 05:32 ET — Premarket iSpecimen Inc shares were down about 15% at around $0.30 in premarket trading on Wednesday. The Nasdaq-listed biospecimen marketplace said it priced a roughly $5.5 million private placement, issuing 6,875 shares of newly designated Series C convertible preferred stock at $800 each. The preferred carries a $1,000 stated value and converts into common shares at 85% of the prior day’s close, and the company said it expects to file a Form 8-K with additional details. GlobeNewswire That structure matters because convertible preferred stock is a security that can be swapped for
